Bibliografías temáticas / Theophylline

Literatura académica sobre el tema "Theophylline"

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 7 de septiembre de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Índice

Artículos de revistas
Tesis
Libros
Capítulos de libros
Actas de conferencias
Informes

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Theophylline".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Theophylline"

Tatsis, G., J. Danos, M. Gaga, D. Pantelakis, M. Veslemes y J. Jordanoglou. "A Single-Blind Crossover Study of Two Different Slow Release Theophylline Preparations". Journal of International Medical Research 16, n.º 6 (noviembre de 1988): 452–58. http://dx.doi.org/10.1177/030006058801600607.

Texto completo

Resumen

In a single-blind crossover study, two slow release theophylline preparations were evaluated in 18 patients with chronic bronchitis or asthma without cardiac, renal or liver disease. After randomization into two groups, patients were treated, in a crossover study design, with 600 mg choline theophyllinate or 300 mg anhydrous theophylline administered orally every 12 h for 7 days. A 2-day washout period separated the two periods of treatment evaluation. Blood samples in which plasma theophylline concentration was to be measured were taken at 7.30 a.m., 2.00 p.m. and 7.30 p.m. during the last 5 days of therapy with each drug. The mean fluctuation in plasma theophylline concentration was ≤40% in all 18 patients taking choline theophyllinate yet in only 15 (83%) patients administered anhydrous theophylline. Salbutamol inhaler was more frequently required for the relief of bronchospasm when taking anhydrous theophylline than when taking choline theophyllinate (total of 41 vs 25 puffs, respectively, over 7 days). Drug-related adverse reactions occurred in four patients while taking anhydrous theophylline and in one patient while taking choline theophyllinate.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Boner, A. L., G. De Stefano, G. Vallone, M. Plebani y P. Ventura. "Absolute and Relative Bioavailability of a Slow Release Theophylline Preparation in Asthmatic Children". Journal of International Medical Research 15, n.º 5 (septiembre de 1987): 282–92. http://dx.doi.org/10.1177/030006058701500504.

Texto completo

Resumen

This study was carried out on 14 asthmatic childen aged 7–13 years. They all received three preparations (aminophylline by intravenous infusion, lysine theophyllinate orally in solution and slow release theophylline orally as capsules) in a single dose of 100 mg active ingredient in a crossover design. Plasma theophylline concentrations, determined by a fluorescent polarization immunoassay, were evaluated both by compartmental and non-compartmental analysis. After administration of slow release theophylline, its maximum plasma concentration and the time needed to reach this were (± SD) 3.19 ± 0.63 μg/ml and 8.71 ± 2.30 h, respectively, compared to 4.51 ± 0.94 μg/ml and 1.96 ± 0.85 h, respectively, for the oral normal release solution. Mean absolute and relative percentage bioavailabilities for slow release theophylline in asthmatic children were (± SD) 92.7 ± 23.2% and 83.14 ± 14.69%, respectively. These are similar to the values found with other slow release formulations in paediatric patients.

Los estilos APA, Harvard, Vancouver, ISO, etc.

BRODWALL, ERLING K. "The Resorption of Theophyllamine (Theophylline Ethylenediamine)". Acta Medica Scandinavica 146, n.º 2 (24 de abril de 2009): 123–26. http://dx.doi.org/10.1111/j.0954-6820.1953.tb10222.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Nolte, Matthias, Ingo Pantenburg y Gerd Meyer. "Konkurrierende Liganden: Theophyllin als nicht- und stark koordinierender Ligand in Quecksilber(II)-Komplexen / Competing Ligands: Theophylline as Non- and Strongly Coordinating Ligand in Mercury(II) Complexes". Zeitschrift für Naturforschung B 61, n.º 6 (1 de junio de 2006): 758–65. http://dx.doi.org/10.1515/znb-2006-0617.

Texto completo

Resumen

[{Hg(CF3)2}(ThpH)(H2O)](H2O) (1), [{Hg4(Thp)4}(ClO4)4(H2O)8](H2O)4 (2), [{Hg(ThpH)2} (NO3)](NO3) (3) and {Hg(Thp)Cl}(H2O) (4) (ThpH = theophylline, C7H8N4O2) have been synthesized by slow evaporation of aqueous solutions of the mercuric salts Hg(CF3)2, Hg(ClO4)2, Hg(NO3)2, or HgCl2 and theophylline. Their crystal structures were determined on the basis of single crystal X-ray data. The coordination polymers 1 and 2 crystallize with triclinic symmetry, P1̅ (no. 2), with a = 468.8(2), b = 1256.4(5), c = 1445.5(6) pm, α = 67.15(3), β = 89.21(3), γ = 89.40(3)° and a = 833.6(1), b = 1862.7(2), c = 2182.9(2) pm, α = 111.61(1), β = 90.98(1), γ = 95.51(1)°, respectively. 3 and 4 crystallize with monoclinic symmetry, Pc (no. 7), a =1194.1(1), b=1258.8(2), c=735.5(2) pm, β =96.96(2)° and P21/n (no. 14), a=1069.0(2), b =911.6(1), c=1089.9(2) pm and β = 96.87(2)°. In 1 the theophylline molecules are non-coordinating to mercury and leave the Hg(CF3)2 molecule unchanged. Only weak electrostatic attractions to one keto-oxygen atom of theophylline and one water molecule hold this co-crystallisate together. In 2, the theophyllinate anion, Thp−, strongly coordinates with both N(7) and N(9) to HgII forming a large ring with eight Hg atoms that incorporates the water molecules. One sort of nitrate ions in 3 is weakly attached to HgII with the theophylline molecules still bound strongly through N(9). The chloride ligand and the theophyllinate ion seem to have the same strengths as ligands in 4 as they are both attached to HgII with the shortest distances possible

Los estilos APA, Harvard, Vancouver, ISO, etc.

Wang, L. C., S. F. Man y A. N. Belcastro. "Metabolic and hormonal responses in theophylline-increased cold resistance in males". Journal of Applied Physiology 63, n.º 2 (1 de agosto de 1987): 589–96. http://dx.doi.org/10.1152/jappl.1987.63.2.589.

Texto completo

Resumen

The effects of theophylline (a phosphodiesterase inhibitor-adenosine receptor antagonist) and substrate feeding (Ensure, 250 kcal/235 ml) on cold resistance were studied in seminude males undertaking submaximal (50% maximum O2 consumption), intermittent (34% of total time) exercise in the cold (-5 to 15 degrees C, individually adjusted) for 3 h. Each subject (n = 7) served as his own control and was tested on a weekly schedule. Under control treatment, rectal temperature (Tre) decreased by 0.9 degrees C to approximately 36.2 degrees C after cold exposure, whereas under theophylline and Ensure, the decrease of Tre was only 0.4 degrees C, indicating a significant increase (P less than 0.05) in cold resistance (50% better than control). The plasma concentration of theophylline was 4.8–5.9 micrograms/ml and was positively correlated with plasma concentration of free fatty acids. Plasma norepinephrine (NE) increased significantly during cold exposure; the absolute concentration was significantly higher after theophylline pretreatment. The plasma concentrations of glucose, epinephrine, cortisol, and adenosine 3′,5′-cyclic monophosphate did not change and the changes of free thyroxine and triiodothyronine were minor. Together, the effectiveness of theophylline + Ensure in acutely increasing cold resistance may be due to increased substrate availability for thermogenesis, part of which, through theophylline's potentiation of both sympathetic release of NE and NE-stimulated lipolysis and part of which, through supplementary feeding of Ensure.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Jeong, Chan Su, Soon Chul Hwang, Daniel W. Jones, Hwan Sun Ryu, Kieho Sohn y Charles D. Sands. "Theophylline Disposition in Korean Patients with Congestive Heart Failure". Annals of Pharmacotherapy 28, n.º 3 (marzo de 1994): 396–401. http://dx.doi.org/10.1177/106002809402800319.

Texto completo

Resumen

OBJECTIVE: This study proposed to determine the systemic disposition on of theophyllinein Korean adult patients during decompensated congestive heart failure compared with disposition after recovery. DESIGN: An experimental, prospective, self-controlled, non randomized design was used. SETTING: The study was performed in a general communityhospital located in Pusan, Korea. PATIENTS: Eight nonsmoking elderly Korean patients with decompensated congestive heart failure presenting to the emergency department were included in the study. Consecutive patients who met entrance criteria were selected. All patients completed the study. INTERVENTIONS: A single dose of aminophylline 6 mg/kg was administered by intravenous infusion over 30 minutes. Standard methods of congestive heart failure therapy were used in each patient, including bed rest, restriction of sodium, and drug therapy including digoxin. After compensation of congestive heart failure was achieved the theophylline infusion was repeated. OUTCOME MEASURES: Serum theophylline concentrations were measured at 2, 6, 12, and 18 hours after completion of the dose at base line and following treatment. RESULTS: A clinically and statistically significant improvement in mean theophylline total body clearance was demonstrated following treatment (from 21.7 ± 2.8 to 43.4 ± 4.7 mL/kg/h [mean ± SEM]; p<0.01). Comparison of these results with a computer model based on literature averages of peoples of all nationalities showed significant underprediction of theophylline clearance both before (p<0.05)and after (p<0.01) treatment. The theophylline elimination half-life prior to treatment was 18.2 ± 2.2 hours and decreased to 9.1 ± 0.8 hours following treatment(p<0.O1). There was no statistical difference between the computer-model predicted initial theophylline half-life and the measured value, but the model significantly underpredicted the improvement following treatment. CONCLUSIONS: The improvement in theophylline clearance demonstrated in this study appears to be greater than that reported for Western patients. This has practical application to the calculation of appropriate theophylline maintenance dosage regimens in Korean patients with cardiac failure. These data support the need for consideration of racial differences in individualizing dosage regimens. We suggest that all kinetic models, whether software supported or not, should consider incorporating ethnic origin as a demographic factor that helps select the proper model for individual patients.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Rees, Sharon. "THEOPHYLLINE". Journal of Prescribing Practice 3, n.º 2 (2 de febrero de 2021): 52. http://dx.doi.org/10.12968/jprp.2021.3.2.52.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

&NA;. "Theophylline". Reactions Weekly &NA;, n.º 728 (noviembre de 1998): 12. http://dx.doi.org/10.2165/00128415-199807280-00041.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

&NA;. "Theophylline". Reactions Weekly &NA;, n.º 1167 (septiembre de 2007): 26. http://dx.doi.org/10.2165/00128415-200711670-00078.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

&NA;. "Theophylline". Reactions Weekly &NA;, n.º 1152 (mayo de 2007): 25–26. http://dx.doi.org/10.2165/00128415-200711520-00078.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Más fuentes

Tesis sobre el tema "Theophylline"

Awosika, Ajoritsedere. "Biopharmacy of sustained-release theophylline". Thesis, University of Bradford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.257819.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Purkiss, Ronald. "Bioequivalence of sustained release theophylline formulations". Thesis, Aston University, 1986. http://publications.aston.ac.uk/12472/.

Texto completo

Resumen

The bioequivalence of sustained release theophylline formulations, marketed in the United Kingdom, has been investigated in relation to the co-administration of food in both single dose and steady state volunteer studies. The effect of food on pharmacokinetic parameters and their clinical relevance was researched. Experimentation using drug induced modification of gastric motility to ascertain the component influences of the rate of gastric emptying on the absorption of theophylline from sustained release formulations was conducted. Prolongation of time to maximum plasma theophylline concentration by food reported in the literature and its clinical importance was investigated in once daily compared with twice daily administration of sustained release theophylline formulations and smoking habit. The correlation between saliva and plasma theophylline concentrations as a means of developing a non-invasive sampling techniques was examined. Data obtained from in vitro dissolution studies was compared with in vivo results. This thesis has shown no significant differences occurred in the pharmacokinetic parameters measured between sustained release formulations available in the United Kingdom. The investigations into the influence of food on prolongation of time to maximum plasma theophylline concentration and other measured pharmacokinetic parameters demonstrated no important pharmacokinetic or clinical effects. Smoking adults taking sustained release theophylline formulations had similar drug clearances to those reported in the literature for smokers taking plain uncoated theophylline formulations.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Boer, Jason. "Mechanistic investigation of cytochrome P450 1A2 catalyzed metabolism of 8-alkylxanthines /". Thesis, Connect to this title online; UW restricted, 2003. http://hdl.handle.net/1773/8161.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Zhang, Shuo. "Physical properties and crystallization of theophylline co-crystals". Licentiate thesis, KTH, Transport Phenomena, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-13255.

Texto completo

Resumen

This work focuses on the physical properties and crystallization of theophyline co-crystals. Co-crystals of theophylline with oxalic acid, glutaric acid and maleic acid have been investigated.

The DSC curves of these co-crystals show that their first endothermic peaks are all lower than the melting temperature of theophylline. The decomposition temperature of theophylline – oxalic acid co-crystal is at about 230 °C, determined by DSC together with TGA. After decomposition, the remaining theophylline melts at about 279 °C, which is higher than the known melting temperature of theophylline, suggesting a structure difference, ie. a new polymorph may have been formed. The formation of hydrogen bonds in theophylline – oxalic acid co-crystal was investigated by FTIR. Changes of FTIR peaks around 3120 cm^-1 reflects the hydrogen bond of basic N of theophylline and hydroxyl H of oxalic acid. The solubility of theophylline – oxalic acid co-crystal and theophylline – glutaric acid co-crystal was determined in 4:1 chlroform – methanol and in pure chloroform respectively. At equilibrium with the solid theophylline – oxalic acid co-crystal, the theophylline concentration is only 60 % of the corresponding value for the pure solid theophylline. At equilibrium with the solid theophylline – glutaric acid co-crystal, the theophylline concentration is at least 5 times higher than the corresponding value for the pure solid theophylline. Two phases of theophylline were found during the solubility determination. In the chloroform – methanol mixture (4:1 in volume ratio) the solubility of the stable polymorph of theophylline is found to be about 14 % lower than that of the metastable phase. Various aspects of the phase diagram of theophylline – oxalic acid co-crystal was explored.

Theophylline – oxalic acid co-crystal has been successfully prepared via primary nucleation from a stoichiometric solution mixture of the two components in chloroform – methanol mixture. By slurry conversion crystallization, the co-crystal can be prepared in several solvents, and yield and productivity can be significantly increased. Theophylline – glutaric acid can be successfully prepared via both co-grinding of the two components and slow evaporation with seeding.

QC20100608

Los estilos APA, Harvard, Vancouver, ISO, etc.

Chrystyn, H. "Pharmacodynamics of theophylline in irreversible chronic airflow obstruction". Thesis, University of Bradford, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.379859.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Chen, Chi. "Engineering of inhalation aerosols combining theophylline and budesonide". Thesis, University of Bradford, 2014. http://hdl.handle.net/10454/14072.

Texto completo

Resumen

In asthma therapy, the use of theophylline to prevent bronchial spasm and glucocorticoids to decrease inflammation is widely indicated. Apart from the acute asthma attack oral theophylline is treated for chronic therapy in order to minimize inflammation and to enhance the efficiency of corticosteroids and recover steroids’ anti-inflammatory actions in COPD treatment. The preferred application route for respiratory disease treatment is by inhalation, such as dry powder inhalers (DPI) being the delivery systems of first choice. As shown recently, there is an advantageous effect if the drugs are given simultaneously which is caused by a synergistic effect at the same target cell in the lung epithelia. Therefore, it seems rational to combine both substances in one particle. This type of particle has the advantage over a combination product containing both drugs in a physical mixture which occurs rather randomly deposition leading to API segregation and non-dose-uniformity. Dry powder inhalers (DPIs) is a type of therapeutic pharmaceutical formulations usually present in the solid form. Due to the nature of the solid-state, an understanding of chemical and physical properties must be established for acquiring optimum performance of the active pharmaceutical ingredients (APIs). In recent year, generation of DPIs is a destructive procedure to meet the micron size. Such processes are inefficient and difficult to control. Moreover, according to current researches on combination APIs formulation, this type of DPIs performed a greater variability in does delivery of each active, leading to poor bioavailability and limit clinical efficient. This result suggest that combination formulations require advanced quality and functionality of particles with suitable physicochemical properties. Hence, in order to production of binary and combination DPIs products, the aim of this study was to develop the spray drying and ultrasonic process for engineering of combination drug particles that will be delivered more efficiently and independently of dose variations to the lung. Microparticles were produced by spray drying or/and ultrasonic technique. The processing parameters and addition of excipients (polymers) were optimized using a full factorial design such that microparticles were produced in a narrow size range suitable for inhalation. Employing excipients resulted in high saturation environment leading to minimized sphere particles when compared to conventional solvent. Solid state characterization of microparticles using powder x-ray diffraction and differential scanning calorimetry indicated that the particles contained crystalline but no cocrystal. The combination particles comparable to or better than micronized drug when formulated as a powder blended with lactose. It was concluded that the use of HPMC enhanced crystallinity suitable for inhalation; and combination particles improved uniform distribution on the stage of NGI.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Babey, Anna Marie. "Characterization of the time course of the effects of theophylline administration on adenosine receptors in cultured murine neuroblastoma cells". Thesis, McGill University, 1994. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=28668.

Texto completo

Resumen

This thesis examines the effects of continuous theophylline pretreatment on the A$ sb2$ adenosine receptor system in cultured murine neuroblastoma cell lines, which either do or do not also express A$ sb1$ adenosine receptors. N-Ethylcarboxamido adenosine (NECA) stimulates cAMP accumulation and binds to A$ sb2$ receptors in a saturable and biphasic fashion in both types of cell cultures. Sixteen hours of theophylline treatment led to a significant increase in the number of low affinity A$ sb2$ binding sites, as well as a potentiation of NECA-stimulated cAMP accumulation, regardless of whether the cells expressed A$ sb1$ receptors. The enhanced adenylate cyclase stimulation in cells treated for 8 hours is completely blocked by addition of cycloheximide, indicating that new protein synthesis plays a role in the effects of theophylline. The potentiated response to NECA continues through 1 week of treatment in both sets of cultured cells, but disappears after 2 weeks of theophylline pretreatment in the cells expressing both A$ sb1$ and A$ sb2$ receptors. Binding profiles in cells that do not express A$ sb1$ receptors demonstrate that while control cells are sensitive to the effects of the non-hydrolyzable analogue of guanosine triphosphate, Gpp(NH)p, cells that were treated for 4 days or 1 week with theophylline are no longer sensitive to the effects of this compound. This could indicate either an enhanced coupling between the receptor and the stimulatory guanine nucleotide regulatory protein (G$ rm sb{s}$ protein) or a complete uncoupling of these two proteins. There is a significant decrease in the basal cAMP levels after 4 days or more of treatment, as well as an increase in the immunoreactivity of the $ alpha$ subunit of the stimulatory G protein after 2 weeks of treatment. Taken together, these findings would tend to favour the possibility of enhanced coupling between the receptor and the G$ rm sb{s}$ protein. Cells that express both receptor subtypes also show

Los estilos APA, Harvard, Vancouver, ISO, etc.

LABOULAYE, PHILIPPE. "Les intoxications a la theophylline : indications therapeutiques a propos de trois observations". Amiens, 1989. http://www.theses.fr/1989AMIEM017.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Haarberg, Hans Eirik. "Theophylline IMAGEtags (intracellular multi aptamer genetic tags) the development and evaluation of an RNA reporter system based on the theophylline aptamer /". [Ames, Iowa : Iowa State University], 2009. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:1464205.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

JOSROLLAND, MONIQUE. "Les dosages de la theophylline dans les milieux biologiques". Strasbourg 1, 1987. http://www.theses.fr/1987STR10728.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Más fuentes

Libros sobre el tema "Theophylline"

Maes, R. A. A. Theophylline profile. Weinheim, F.R.G: VCH, 1985.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

A, Maes Robert A., Oellerich Michael y Enders Peter W, eds. Theophylline profile. Weinheim: VCH, 1985.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Friedrich, Kummer, ed. Asthma: Structural body-Theophylline today = strukturelle Grundlagen--Theophyllin heute. New York: Springer-Verlag, 1995.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Hughes, Angela. A theophylline compliance study. Ottawa: Ottawa Civic Hospital, 1990.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Jackson, Stephen Hugh David. Clinical aspects of theophylline pharmacokinetics. Birmingham: University of Birmingham, 1987.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Purkiss, Ronald. Bioequivalence of sustained release theophylline formulations. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1986.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Bowen, James Marshall. Theophylline biotransformation by human lung microsomes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1993.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Minton, Neil Andrew. The clinical pharmacology and toxicology of theophylline. Birmingham: University of Birmingham, 1993.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Shilalukey, Kathleen. Are current pediatric dose recommendations for intravenous theophylline appropriate? Ottawa: National Library of Canada, 1993.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

He, Juan. Theophylline 7-[beta]-D ribofuranoside production in mammalian tissues. Ottawa: National Library of Canada, 1994.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Más fuentes

Capítulos de libros sobre el tema "Theophylline"

Al-Qadheeb, Nada S. "Theophylline". En Textbook of Clinical Pediatrics, 2643–45. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_281.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Bährle-Rapp, Marina. "Theophylline". En Springer Lexikon Kosmetik und Körperpflege, 553. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-71095-0_10485.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Wilson, John Fawcett. "Theophylline". En The Immunoassay Kit Directory, 1613–25. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0679-5_49.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Prentice, Bernadette, Adam Jaffe y Paul S. Thomas. "Theophylline". En Compendium of Inflammatory Diseases, 1252–54. Basel: Springer Basel, 2016. http://dx.doi.org/10.1007/978-3-7643-8550-7_53.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ellis, Elliot F. "Theophylline". En Allergic Diseases, 345–60. Totowa, NJ: Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-007-0_19.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Gong, Li-Li, Li-Da Du y Guan-Hua Du. "Theophylline". En Natural Small Molecule Drugs from Plants, 469–74. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-8022-7_78.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Arampatzis, Adamantios, Lida Mademli, Thomas Reilly, Mike I. Lambert, Laurent Bosquet, Jean-Paul Richalet, Thierry Busso et al. "Theophylline". En Encyclopedia of Exercise Medicine in Health and Disease, 849. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_3117.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Barnes, Peter J. "Theophylline". En Current Review of Asthma, 173–84. London: Current Medicine Group, 2003. http://dx.doi.org/10.1007/978-1-4613-1095-2_17.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Prentice, Bernadette, Adam Jaffe y Paul S. Thomas. "Theophylline". En Encyclopedia of Inflammatory Diseases, 1–4. Basel: Springer Basel, 2014. http://dx.doi.org/10.1007/978-3-0348-0620-6_53-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Bährle-Rapp, Marina. "Methylsilanol Carboxymethyl Theophylline". En Springer Lexikon Kosmetik und Körperpflege, 354. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-71095-0_6559.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Theophylline"

Nag, Shreya, Debangana Das, Hemanta Naskar, Runu Banerjee Roy, Bipan Tudu y Rajib Bandyopadhyay. "Estimation of Theophylline in Black Tea Using NIR Spectroscopy". En 2020 International Conference on Emerging Frontiers in Electrical and Electronic Technologies (ICEFEET). IEEE, 2020. http://dx.doi.org/10.1109/icefeet49149.2020.9186994.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Mędza, Grzegorz, Jacek Wierzchowski y David Shugar. "Fluorescent analogues of caffeine, theophylline, and other methyl-xanthines". En XIVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2008. http://dx.doi.org/10.1135/css200810478.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Jenkins, C. R., F. Q. Wen, P. J. Barnes, B. R. Celli, N. S. Zhong, J. P. Zheng, A. Martin y N. Berend. "Theophylline and Systemic Corticosteroids in COPD: The TASCS Trial". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7444.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Almagro, Juan. "Hiperuricemic Impact Of Theophylline In A Long-term Administration". En American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1341.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Koniuch, Natalia. "Using transmission electron microscopy to monitor hydration of theophylline". En Microscience Microscopy Congress 2021 incorporating EMAG 2021. Royal Microscopical Society, 2021. http://dx.doi.org/10.22443/rms.mmc2021.255.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Feng, Zhanqin, Xueping Huang, Zengjuan Zheng, Wei Zhang, Shengjian Tang y Weifen Zhang. "The characteristics of theophylline/chitosan microspheres as pulmonary delivery carriers". En International Conference on Medical Engineering and Bioinformatics. Southampton, UK: WIT Press, 2014. http://dx.doi.org/10.2495/meb140631.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Braga, Guilherme S., Leonardo G. Paterno, Fernando J. Fonseca, Manel del Valle y Perena Gouma. "Molecularly Imprinted Polymer Based Sensor for the Detection of Theophylline". En OLFACTION AND ELECTRONIC NOSE: PROCEEDINGS OF THE 14TH INTERNATIONAL SYMPOSIUM ON OLFACTION AND ELECTRONIC NOSE. AIP, 2011. http://dx.doi.org/10.1063/1.3651655.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Singh, Mrityunjaya, Sudhir Kumar Agarwal, Manoj Meena y Shruti Singh. "Effect of low dose theophylline as adjunct in treatment of COPD". En ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa303.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Cooney, Lewis, Daniel Hawcutt y Ian Sinha. "Intravenous theophylline levels in children with acute asthma: A systematic review". En ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa314.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Dubuis, Eric, Mark A. Birrell, Michael Wortley y Maria G. Belvisi. "Theophylline And Theobromine Block Excitation Of Sensory Nerves And Prevent Cough". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5544.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Theophylline"

Adding low dose theophylline to inhaled corticosteroids does not reduce COPD exacerbations. National Institute for Health Research, enero de 2019. http://dx.doi.org/10.3310/signal-000708.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!